نتایج جستجو برای: ژن brca

تعداد نتایج: 18182  

2016
Stephen Murata Catherine Zhang Nathan Finch Kevin Zhang Loredana Campo Eun-Kyoung Breuer

Poly(ADP-ribose) polymerase (PARP) inhibitors have proven to be successful agents in inducing synthetic lethality in several malignancies. Several PARP inhibitors have reached clinical trial testing for treatment in different cancers, and, recently, Olaparib (AZD2281) has gained both United States Food and Drug Administration (USFDA) and the European Commission (EC) approval for use in BRCA-mut...

2010
Joyce O'Shaughnessy

Downloa cer chemotherapy exploits limitations in repairing DNA damage in order to kill proliferating nant cells. Recent evidence suggests that cancers within and across tissue types have specific defects A repair pathways, and that these defects may predispose for sensitivity and resistance to various s of cytotoxic agents. Poly (ADP-ribose) polymerase (PARP) and BRCA proteins are central to th...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Ana M Gonzalez-Angulo Kirsten M Timms Shuying Liu Huiqin Chen Jennifer K Litton Jennifer Potter Jerry S Lanchbury Katherine Stemke-Hale Bryan T Hennessy Banu K Arun Gabriel N Hortobagyi Kim-Anh Do Gordon B Mills Funda Meric-Bernstam

PURPOSE To investigate the incidence of germline and somatic BRCA1/2 mutations in unselected patients with triple-negative breast cancer (TNBC) and determine the prognostic significance of carrying a mutation. METHODS DNA was obtained from 77 TNBC and normal tissues. BRCA1/2 exons/flanking regions were sequenced from tumor and patients classified as mutant or wild type (WT). Sequencing was re...

2011
Crystal Johnson-Holiday Rajesh Singh Erica L Johnson William E Grizzle James W Lillard Shailesh Singh

BACKGROUND Chemotherapy heavily relies on apoptosis to kill breast cancer (BrCa) cells. Many breast tumors respond to chemotherapy, but cells that survive this initial response gain resistance to subsequent treatments. This leads to aggressive cell variants with an enhanced ability to migrate, invade and survive at secondary sites. Metastasis and chemoresistance are responsible for most cancer-...

Journal: :The oncologist 2016
Haley Streff Jessica Profato Yuanqing Ye Denise Nebgen Susan K Peterson Claire Singletary Banu K Arun Jennifer K Litton

BACKGROUND Mutations in the BRCA1 and BRCA2 genes are associated with increased risk of breast, ovarian, and several other cancers. The purpose of the present study was to evaluate the incidence of cancer in first- and second-degree relatives of BRCA mutation carriers compared with the general population. MATERIALS AND METHODS A total of 1,086 pedigrees of BRCA mutation carriers was obtained ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
David J Gallagher Mia M Gaudet Prodipto Pal Tomas Kirchhoff Lisa Balistreri Kinjal Vora Jasmine Bhatia Zsofia Stadler Samson W Fine Victor Reuter Michael Zelefsky Michael J Morris Howard I Scher Robert J Klein Larry Norton James A Eastham Peter T Scardino Mark E Robson Kenneth Offit

PURPOSE Increased prostate cancer risk has been reported for BRCA mutation carriers, but BRCA-associated clinicopathologic features have not been clearly defined. EXPERIMENTAL DESIGN We determined BRCA mutation prevalence in 832 Ashkenazi Jewish men diagnosed with localized prostate cancer between 1988 and 2007 and 454 Ashkenazi Jewish controls and compared clinical outcome measures among 26 ...

2008
C. J. Hess N. Ameziane G. J. Schuurhuis A. Errami F. Denkers G. J. L. Kaspers J. Cloos H. Joenje D. Reinhardt G. J. Ossenkoppele C. M. Zwaan Q. Waisfisz

OBJECTIVE Inactivation of the FA-BRCA pathway results in chromosomal instability. Fanconi anaemia (FA) patients have an inherited defect in this pathway and are strongly predisposed to the development of acute myeloid leukaemia (AML). Studies in sporadic cancers have shown promoter methylation of the FANCF gene in a significant proportion of various solid tumours. However, only a single leukaem...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Khanh Do Alice P Chen

Poly (ADP-ribose) polymerases (PARP) are a family of nuclear protein enzymes involved in the DNA damage response. The role of PARP-1 in base excisional repair has been extensively characterized. More recent in vitro studies additionally implicate a role for PARP-1 in facilitating homologous recombination and nonhomologous end-joining. The more faithful process of homologous recombination repair...

Journal: :The British journal of surgery 2015
A T Manning C Wood A Eaton M Stempel D Capko A Pusic M Morrow V Sacchini

BACKGROUND Nipple-sparing mastectomy (NSM) is associated with improved cosmesis and is being performed increasingly. Its role in BRCA mutation carriers has not been well described. This was a study of the indications for, and outcomes of, NSM in BRCA mutation carriers. METHODS BRCA mutation carriers who underwent NSM were identified. Details of patient demographics, surgical procedures, compl...

Journal: :South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2016
Heather Jessica Seymour Tasha Wainstein Shelley Macaulay Tabitha Haw Amanda Krause

BACKGROUND Germline pathogenic mutations in cancer susceptibility genes result in inherited cancer syndromes. In the Afrikaner population of South Africa (SA), three founder mutations in the BRCA genes that lead to hereditary breast and ovarian cancer syndrome (HBOCS) have been identified. OBJECTIVES To investigate the uptake and type of molecular testing performed on patients for HBOCS, to d...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید